About Biohm® Technologies
On the cutting edge of gut health innovation
- Biohm Technologies is leading the way to better understanding the whole microbiome, including the critical role of the mycobiome, and how these trillions of bacteria and fungi affect health and wellness in people across various walks of life.
- Built on Microbiome Science and Expertise
Dr. Ghannoum is a tenured Professor and Director of the Center for Medical Mycology at the prestigious Case Western Reserve University and University Hospitals Cleveland Medical Center.
- 30+ Years of NIH Funded Research
- 600+ Published Scientific Papers
- 46K+ Publication Citations
- Tier One Research Lab
(according to US News & World Report, 2024)
- Putting the Focus on Fungi
-Dr. Mahmoud Ghannoum
Leadership Team
Meet the innovators leading our mission in microbiome technology

Sam Schatz
CEO and Co-Founder

Dr. Mahmoud Ghannoum
Co-Founder and CSO

Dr. John Deaton
VP of Science & Technology

Diane Alexander
VP of Sales

Kristin Wilhoyte
VP of Marketing

Liz Goodwin
Director of Quality & Regulatory
Proud Members of the Industry’s Leading Trade Associations
Council for Responsible Nutrition (CRN)
The leading trade association for the dietary supplement and functional food industry, recognized for setting high standards in safety, science, and regulatory compliance.
International Probiotics Association (IPA)
Company Milestones
- Dr. Mahmoud Ghannoum publishes research on fungi’s role in the microbiome
2016
- BIOHM Health consumer brand founded by Afif Ghannoum and Dr. Ghannoum
2017
- BIOHM wins NBJ Award for Science and Innovation
2018
- Gut Testing Goes Live
- Two pre-clinical studies published on probiotic blend called BIOHM FX
2019
- BIOHM FX probiotic blend is launched by BIOHM Health
- First human clinical study on BIOHM FX probiotic blend is published
2021
- Symbiont data discovery platform is validated and published in Gastroenterology
2023
- Second human clinical study on BIOHM FX is published
- BIOHM Health’s Total Gut Probiotic, featuring the BIOHM FX blend is awarded Nutraingredients-USA Microbiome Modulation Product of the Year
- Third human clinical study on BIOHM FX is published
- Sam Schatz appointed CEO
- Company rebrands to Biohm Technologies and accelerates B2B offerings with Mycosha™ probiotic (BIOHM FX) and private label gut test kits
2024
News + Events

Join Biohm Technologies at SupplySide Global 2026
SupplySide Global is the premier gathering of health and nutrition professionals, bringing buyers and suppliers together from throughout the industry.

Biohm Technologies Announces Health Canada NPN Approval for Mycohsa™ Probiotic
Biohm Technologies, a leader in microbiome research and product innovation, announced today that Mycohsa™, the company’s clinically supported probiotic blend, has received a Natural Product

Join Biohm Technologies at SupplySide Connect New Jersey 2026
SupplySide Connect New Jersey is the East Coast trade show that delivers an unparalleled networking experience for supplement, food and beverage industry professionals.